Loading clinical trials...
Loading clinical trials...
This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergan
NCT07425522 · Diabetic Macular Edema
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
NCT07449936 · Diabetic Macular Edema, DME, and more
NCT07449923 · Diabetic Macular Edema, DME, and more
NCT06439576 · Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, and more
Retinal Consultants of Phoenix
Phoenix, Arizona
West Coast Retina
San Francisco, California
Orange Co Retina Medical Group
Santa Ana, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions